Delivery Order SPE2DB22D3501-SPE2DB25FXE61
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottle pharmaceutical product with a ceiling value of $1,443.90. Issued on August 5, 2025, this firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this award, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $3,176.58 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA. The product will be delivered to the company's Conshohocken, Pennsylvania location, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 17, 2025, from the Defense Logistics Agency (DLA) for ULTANE 250 ML in pen bottle format. This firm fixed-price, non-set-aside contract has a ceiling value of $2,310.24 and an ultimate completion date of September 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mL of Ultane in a pen bottle configuration, valued at $2,596.98. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ultane 250 ML pen bottles with a ceiling value of $1,347.64. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,202.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ultane 250 ml pen bottles. This firm fixed price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Ultane 250 ml pen bottles. The contract has a ceiling value of $1,251.38 and is classified as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, which is also the company's corporate headquarters. This award was not set aside for small businesses or...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,828.94 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles. This firm fixed-price, non-set-aside contract was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ultane 250 mL pen bottles with a ceiling value of $1,155.12. This firm fixed price delivery order, which must be completed by August 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXE61Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Ultane 250 ML in pen bottle format. This $1,155.12 firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 8, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical supplies, and healthcare commodities to military healthcare systems worldwide. AmerisourceBergen Drug Corp maintains a significant federal contract portfolio with DLA, fulfilling critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's contract awards demonstrate substantial versatility in supplying pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, generic and brand-name drugs, and medical devices. All reviewed awards to the contractor have involved firm fixed-price delivery orders competitively awarded through open competition, reflecting the company's established capability to meet federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/5/25 |